Evidence map›Paper›PMID 42481492›Full record

ArticleNature communications2026

Integrated device for optoacoustically-guided ultrasound surgery.

Isaac Esteban, Nima Mahkam, Yi Chen, Martha Gjikolaj, Beat Werner, Henning Richter, Katrin Beckmann, Edin Nevzati, Daniel Coluccia, Hikari A I Yoshihara and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Isaac EstebanInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.
Nima MahkamInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-5450-4624
Yi ChenInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-3980-9184
Martha GjikolajInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7675-9476
Beat WernerCenter for MR-Research, University Children's Hospital Zurich, Zurich, Switzerland.
Henning RichterDiagnostic Imaging Research Unit (DIRU), Clinic for Diagnostic Imaging, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-3696-6993
Katrin BeckmannDiagnostic Imaging Research Unit (DIRU), Clinic for Diagnostic Imaging, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-1823-7845
Edin NevzatiFaculty of Medicine, University of Basel, Basel, Switzerland.
Daniel ColucciaNeurosurgery, Stadtspital Zurich, Zurich, Switzerland.
Hikari A I YoshiharaInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3274-7147
Frauke SeehusenLaboratory for Animal Model Pathology (LAMP), Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Daniel RazanskyInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland. daniel.razansky@uzh.ch.
Hector EstradaInstitute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland. hector.estrada@pharma.uzh.ch.ORCID http://orcid.org/0000-0002-4345-6695

Funding

Eidgenössische Technische Hochschule Zürich (Federal Institute of Technology Zurich) PHRT-582Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 10.003.762
6 · The paper itself

Abstract

High-intensity focused ultrasound has emerged as a promising tool for treating tumors and other pathologies by inducing localized thermal lesions. However, treatment outcomes depend strongly on accurate coverage of the treated region and monitoring lesion formation in real time. While magnetic resonance imaging has successfully been used to guide high-intensity focused ultrasound therapy, it significantly increases the cost and complexity of the treatment. To address these limitations, we have developed a system that integrates real-time three-dimensional tomographic optoacoustic imaging with concurrent focused ultrasound emission using a high-frequency spherical array transducer. We evaluated the performance of the system in the mouse brain ex vivo and further assessed its clinical translatability in a living sheep, demonstrating successful induction of a confined thermal lesion beneath the cortical surface, as confirmed by magnetic resonance imaging and histology. The system enabled precise treatment targeting, while optoacoustic signal changes during sonication provided a reliable indicator of thermal lesion progression. This capability allowed on-the-fly adjustment of the thermal dose, helping to minimize the risk of vascular damage or adverse effects on off-target structures.

Indexed as

High-Intensity Focused Ultrasound AblationPhotoacoustic TechniquesAnimalsBrainMagnetic Resonance ImagingMiceSheep

Identifiers

PMID42481492
PMCPMC13500822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.